VISION
Inspiring transformational change in the
field of oncology diagnostics
MISSION
To develop and deliver accurate, rapid, minimally
invasive oncology diagnostic products utilising our
patented MCM5 antibodies
Arquer Diagnostics is focused on the development and commercialisation of highly accurate minichromosome maintenance (MCM) protein based non-invasive tests for cancer diagnosis and monitoring.
Arquer aim to meet demand expressed by patients, clinicians and payers for cost-effective healthcare technologies that not only enhance patient care but help to reduce overall healthcare costs by improving patient outcomes.
Arquer aim to meet demand expressed by patients, clinicians and payers for cost-effective healthcare technologies that not only enhance patient care but help to reduce overall healthcare costs by improving patient outcomes.
Latest News
Arquer Diagnostics @Arquer Diagnostics
June is #ProstateCancerMonth, and #Arquer are at the forefront of this battle. We're working with many great #urologists to improve the pathway of #prostate #cancer #diagnostics. https://t.co/aL5eSKZmkj
Arquer Diagnostics @Arquer Diagnostics
#Arquer are pleased to confirm that we're attending #BAUS2019 - the British Annual Urology Society Meeting in Glasgow, on Jun 24-26th, where we'll be presenting #ADXBLADDER and meeting #urologists to create new alliances. https://t.co/j6srTBuKI8
Arquer Diagnostics @Arquer Diagnostics
What a privilege to speak at the Women in #Biopharma #Leadership event on 15 May, together with Jenny Rossiter! A group of talented, motivated and experienced women working together to further excellence in Biopharma. Until next time!
#Arquer #lifesciences #cancer #oncology https://t.co/uvrF6NJnRf
Arquer Diagnostics @Arquer Diagnostics
We are proud to support @WorldBladderCan in their mission to provide #bladdercancer information worldwide, and build #medical alliances to improve #cancerpatient outcomes.
https://t.co/pwETni8AUQ
#bladdercanceraware #Arquer #ArquerDiagnostics #worldbladdercancer https://t.co/Hoy8GDPJFe
Arquer Diagnostics @Arquer Diagnostics
The results of our #ADXBLADDER are consistently excellent, proving the robustness of our non-invasive #cancer #diagnostics technology. #Urologists can now use this urine-based test to benefit patients worldwide. Click, to change #bladdercancer history: https://t.co/TtyefjKLku https://t.co/H8dDKHJvW8
